Glenmark Pharmaceuticals Limited (BOM:532296)
India · Delayed Price · Currency is INR 2,170.50
+1.75 (0.08%)
At close: Mar 27, 2026
Glenmark Pharmaceuticals Revenue
Glenmark Pharmaceuticals had revenue of 39.01B INR in the quarter ending December 31, 2025, with 15.15% growth. This brings the company's revenue in the last twelve months to 165.10B, up 18.26% year-over-year. In the fiscal year ending March 31, 2025, Glenmark Pharmaceuticals had annual revenue of 133.63B with 5.68% growth.
Revenue (ttm)
165.10B
Revenue Growth
+18.26%
P/S Ratio
3.71
Revenue / Employee
10.45M
Employees
15,800
Market Cap
612.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 133.63B | 7.18B | 5.68% |
| Mar 31, 2024 | 126.45B | 9.90B | 8.49% |
| Mar 31, 2023 | 116.56B | -6.49B | -5.28% |
| Mar 31, 2022 | 123.05B | 13.61B | 12.44% |
| Mar 31, 2021 | 109.44B | 2.87B | 2.69% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dr. Reddy's Laboratories | 345.83B |
| Lupin | 261.51B |
| Torrent Pharmaceuticals | 127.42B |
| Jubilant Pharmova | 79.18B |
| Abbott India | 68.24B |
| Granules India | 50.92B |
| J. B. Chemicals & Pharmaceuticals | 41.93B |
| GlaxoSmithKline Pharmaceuticals | 38.01B |
Glenmark Pharmaceuticals News
- 5 days ago - Pharma sector stocks today, March 24: Shilpa Medicare jumps 3.28%, Glenmark Pharma up 1.36%, Laurus Labs gain 1.65% - Business Upturn
- 6 days ago - Pharma sector stocks today, March 23: Alembic Pharma down 2.24%, Ajanta Pharma falls 1.85%, Glenmark Pharma falls 1.98% - Business Upturn
- 10 days ago - Pharma sector stocks fall today, March 19: Biocon down 2.33%, Laurus Labs falls 2.29%, Glenmark Pharma drops 2% - Business Upturn
- 10 days ago - Glenmark Pharmaceuticals launches authorised generic to Savella tablets in the US - Business Upturn
- 10 days ago - Glenmark Pharmaceuticals receives US FDA approval for Fluticasone Propionate Nasal Spray - Business Upturn
- 13 days ago - Pharma sector stocks today, March 16: Suven Life up 3.46%, Glenmark Pharma surge 1.39%, Divis Lab rises 0.36% - Business Upturn
- 18 days ago - Pharma sector stocks today, March 11: Natco Pharma falls 1.35%, Alembic Pharma surge 1.33%, Glenmark Pharma up 1.41% - Business Upturn
- 19 days ago - Pharma sector stocks surge today, March 10: Natco Pharma up 4%, Granules India jumps 3.31%, Glenmark Pharma rises 2.72% - Business Upturn